Travere Therapeutics (TVTX) shares outstanding

Shares outstanding · fiscal 2025
89.21M

Travere Therapeutics (TVTX) had 89.21M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 13.1% higher than the 78.89M of fiscal 2024. Figures as of 18 Nov 2026, 12:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
89.21M
Change on fiscal 2024
+13.1%
Growth, 5 years
+13.4% a year
Growth, 10 years
+9.0% a year
Highest on record
89.21Mfiscal 2025
Lowest on record
14.21Mfiscal 2013
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Travere Therapeutics shares outstanding, in more detail

The market data feed counts 95.99M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 13.4% a year; over ten years the rate was 9.0% a year. Across the 13 fiscal years on record (2013–2025), the highest was 89.21M in fiscal 2025 and the lowest 14.21M in fiscal 2013.

History · 13 fiscal years

Shares outstanding by fiscal year

Travere Therapeutics shares outstanding, year by year

Travere Therapeutics (TVTX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202589.21M 13.1% up
202478.89M 6.2% up
202374.27M 16.5% up
202263.76M 6.6% up
202159.83M 25.9% up
202047.54M 12.3% up
201942.34M 4.7% up
201840.43M 4.3% up
201738.77M 1.3% up
201638.29M 1.9% up
201537.58M 50.0% up
201425.06M 76.4% up
201314.21M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Travere Therapeutics and comparable companies
CompanyShares outstandingFiscal year
MiniMed Group MMED256.60M2026
Adaptive Biotechnologies ADPT151.72M2025
Heartflow HTFL36.85M2025
CRISPR Therapeutics CRSP89.93M2025
Travere Therapeutics TVTX89.21M2025
Option Care Health OPCH163.37M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TVTX

Travere Therapeutics, figure by figure

Travere Therapeutics (TVTX) overview: price, valuation and scorecardAll health care companies by market value

Travere Therapeutics shares outstanding: questions and answers

How many shares does Travere Therapeutics have?

Travere Therapeutics (TVTX) had 89.21M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 13.1% higher than the 78.89M of fiscal 2024. The market data feed counts 95.99M shares outstanding today.

What is the growth rate of Travere Therapeutics's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 13.4% a year; over ten years the rate was 9.0% a year.

What are the highest and lowest diluted share count figures on record for Travere Therapeutics?

Across the 13 fiscal years on record (2013–2025), the highest was 89.21M in fiscal 2025 and the lowest 14.21M in fiscal 2013.

How is Travere Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Travere Therapeutics it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Travere Therapeutics (TVTX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/TVTX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.